Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer

Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer
p p Read More

New data shows nearly three‑year median overall survival

September 14, 2026 News

NICE backs ibrutinib regimen for untreated mantle cell lymphoma

NICE backs ibrutinib regimen for untreated mantle cell lymphoma
p p Read More

Guidance offers first alternative to transplant‑based first‑line care

September 10, 2026 News

Livdelzi accepted in Scotland for treatment of PBC

Livdelzi accepted in Scotland for treatment of PBC
p p Read More

SMC decision expands options for people with chronic itch

September 9, 2026 News

FDA approves Tivicay pd for youngest HIV patients

FDA approves Tivicay pd for youngest HIV patients
p p Read More

New treatment option expands paediatric HIV care access

September 3, 2026 News

Koala trial doses first patient with novel KMA‑targeting CAR‑T

Koala trial doses first patient with novel KMA‑targeting CAR‑T
p p Read More

Australian teams advance first‑in‑human multiple myeloma therapy

September 2, 2026 News

Heparegenix wins orphan drug status for darizmetinib

Heparegenix wins orphan drug status for darizmetinib
p p Read More

Designation supports development for post‑hepatectomy liver failure

September 2, 2026 News

IMAVVY approved as first targeted therapy for wAIHA

IMAVVY approved as first targeted therapy for wAIHA
p p Read More

New treatment reduces pathogenic IgG while preserving B‑cell function

September 1, 2026 News

Nxera partner gains acceptance for NBI‑1117567

Nxera partner gains acceptance for NBI‑1117567
p p Read More

Phase 2 study to assess muscarinic M1 agonist in Alzheimer’s cognition

September 1, 2026 News

Jemperli accepted for priority review by US FDA

Jemperli accepted for priority review by US FDA
p p Read More

sBLA covers dMMR/MSI‑H stage II–III rectal cancer

August 31, 2026 News

Carterra supports AI‑designed protein study with HT-SPR platforms

Carterra supports AI‑designed protein study with HT-SPR platforms
p p Read More

Anthropic, twist and Adaptyv validate 1,320 binders across 15 targets

August 31, 2026 News

Posts navigation

Posts pagination

« Previous 1 … 3 4 5 … 100 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy